Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Management of the unholy trinity diabetes-obesity-hypertension (diabesotension).

Sharabi Y.

Diabetes Metab Res Rev. 2012 Nov 20. doi: 10.1002/dmrr.2371. [Epub ahead of print]

PMID:
23169567
2.

The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.

Khan NA, McAlister FA, Lewanczuk RZ, Touyz RM, Padwal R, Rabkin SW, Leiter LA, Lebel M, Herbert C, Schiffrin EL, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, DeChamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Campbell NR, Arnold M, Moe G, Hill MD, Jones C, Larochelle P, Ogilvie RI, Tobe S, Houlden R, Burgess E, Feldman RD; Canadian Hypertension Education Program..

Can J Cardiol. 2005 Jun;21(8):657-72.

PMID:
16003449
3.

[Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].

Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.

Nefrologia. 2008;28 Suppl 3:39-48. Spanish.

4.

The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C; Canadian Hypertension Education Program..

Can J Cardiol. 2004 Jan;20(1):41-54.

PMID:
14968142
5.

The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.

Khan NA, McAlister FA, Rabkin SW, Padwal R, Feldman RD, Campbell NR, Leiter LA, Lewanczuk RZ, Schiffrin EL, Hill MD, Arnold M, Moe G, Campbell TS, Herbert C, Milot A, Stone JA, Burgess E, Hemmelgarn B, Jones C, Larochelle P, Ogilvie RI, Houlden R, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, Dechamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Tobe S, Touyz RM; Canadian Hypertension Education Program..

Can J Cardiol. 2006 May 15;22(7):583-93.

6.

Meeting the challenge to improve the treatment of hypertension in blacks.

Lopes AA, James SA, Port FK, Ojo AO, Agodoa LY, Jamerson KA.

J Clin Hypertens (Greenwich). 2003 Nov-Dec;5(6):393-401. Review.

7.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
8.

Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan.

da Silva PM.

Clin Drug Investig. 2010;30(9):625-41. doi: 10.2165/11538440-000000000-00000. Review.

PMID:
20626210
9.

ESH-ESC guidelines for the management of hypertension.

Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B.

Herz. 2006 Jun;31(4):331-8.

PMID:
16810473
10.

Current recommendations for the treatment of hypertension: are they still valid?

Moser M.

J Hypertens Suppl. 2002 Feb;20(1):S3-10.

PMID:
11996197
11.
12.

Management issues in the metabolic syndrome.

Deedwania PC, Gupta R.

J Assoc Physicians India. 2006 Oct;54:797-810. Review.

PMID:
17214277
13.

Hypertension in people with Type 2 diabetes: knowledge-based diabetes-specific guidelines.

Working Party of the International Diabetes Federation (European Region)..

Diabet Med. 2003 Dec;20(12):972-87. Review.

PMID:
14632698
14.

What have we learned from the current trials?

Abbott KC, Bakris GL.

Med Clin North Am. 2004 Jan;88(1):189-207. Review.

PMID:
14871059
15.

The future of antihypertensive treatment.

Israili ZH, Hernández-Hernández R, Valasco M.

Am J Ther. 2007 Mar-Apr;14(2):121-34. Review.

PMID:
17414579
16.

Blood pressure control and nephroprotection in diabetes.

Abbott K, Basta E, Bakris GL.

J Clin Pharmacol. 2004 Apr;44(4):431-8. Review.

PMID:
15051752
17.

Update on calcium antagonists and the kidney.

Tobe S.

Curr Opin Nephrol Hypertens. 2003 May;12(3):309-15. Review.

PMID:
12698071
18.
19.

[Are all antihypertensive drugs renoprotective?].

Wolf S, Risler T.

Herz. 2004 May;29(3):248-54. Review. German.

PMID:
15167950
20.

Supplemental Content

Support Center